Sublingual hyposensitization;L'hyposensibilisation par voie sublinguale

Revue Medicale de Bruxelles

Volumn 25, Issue 4, 2004, Pages

  Halloy, J L ^a  

^a CHR Saint Joseph   (Belgium)

Author keywords

Adverse effects; Immunotherapy; Mode of action; Practical aspect; Sublingual way

Indexed keywords

ALLERGEN; POLLEN ANTIGEN;

ABDOMINAL PAIN; ALLERGY; DESENSITIZATION; DRUG EFFICACY; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; POLLEN ALLERGY; REVIEW; SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; DESENSITIZATION, IMMUNOLOGIC; HUMANS;

EID: 5044236715     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Bousquet J, Lockey RF, Malling HJ: World Health organisation: allergen immunotherapy. Allergy 1998; 53 (Suppl 44): 1-42
2. Bousquet J, Van Cauwenberghe P: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl): S240-5
3. Mübeccel A, Carsten Schmidt W, Marek J, Cezmi A, Blaser K: Mechanism of Allergen Immunotherapy. Allergy and Clin Immunol International 2004; 16: 65-9
4. Wachholz PA, Soni, NK, Till SJ, Durham SR: Inhibition of allergen-IgE binding to B-cells by IgG antibodies following grass pollen immunotherapy. J Allergy Clin Immunol 2003; 112: 915-22
5. Novak N, Allam JP, Betten H, Haberstock J, Bieber T: The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 2004; 59: 5-14
6. Muller U, Mosbech H: Position paper: Immunotherapy with Hymenoptera venoms. Allergy 1993; 48 (Suppl): 37-46
7. Abramson MJ, Puy RM, Weiner JM: Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-74
8. Durham S, Walker S, Varga E et al: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75
9. Jacobsen L, Dreborg S, Moller C et al: Immunotherapy as a preventive treatment. J Allergy Clin Ummunol 1996; 97: 232
10. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensibilisations in children. J Allergy Clin Immunol 1997; 99: 450-3
11. Kinchi MS, Poulsen F, Carat F, André C, Hansen AB, Malling HJ: Clinical efficacy of sublingual and subcutaneous birch pollen allergen specific immunotherapy: a randomised, placebo controlled, double blind, double dummy study. Allergy 2004; 59: 45-53
12. Canonica GW, Passalacqua G: Non injection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-48
13. Passalaqua G, Canonica GW: L'immunothérapie locale. Qu'en est-il à ce jour? Revue Française d'Allergologie 1998; 38: 657-65